WCLC 2025 - Posters & ePosters-P3.18.81 A Phase II Study of First-Line Sintilimab Combined With Anlotinib and Platinum-Based Chemotherapy in Unresectable MPM

P3.18.81 A Phase II Study of First-Line Sintilimab Combined With Anlotinib and Platinum-Based Chemotherapy in Unresectable MPM

Asset Subtitle

Xinyu Wu

Meta Tag

Speaker Xinyu Wu

Topic Clinical Trials in Progress